You are here: Industry Insights > API

News List

The National Healthcare Security Administration announced a price reduction for hydrocortisone acetate tablets PharmaSources/Laoxue
June 08, 2023
The price is back to the level of about two years ago, and the result is not to stop taking the drug.
The ingredient of a traditional Chinese medicine was found to be cockroaches Mr. Xue/PharmaSources
May 12, 2023
"The ingredient of a traditional Chinese medicine was found to be cockroaches" is trending. Some enterprises have reached an output value worth over RMB100 million long ago because of it.
WHO Prequalifies Ethionamide for Indian firm SHEM OIRERE
May 04, 2023
The World Health Organization (WHO) in early April 2023 pre-qualified ethionamide, manufactured by Indian pharmaceutical company, Micro Labs Limited.
With First Chinese Small-molecule Oral Drug for COVID-19 Coming, What New Opportunities are Ushered in by the Relevant Industry Chain？ PharmaSources.com/Yefenghong
May 23, 2022
News about the progress of Chinese small-molecule oral antiviral drug for COVID-19 has been disclosed in recent days and the related R&D ushers in a critical point.
Spinosad Powder Manufacturers in China PharmaSources
August 16, 2021
Spinosad is a naturally occurring substance. It is produced by a soil bacterium. Spinosad is toxic to insects and is a mixture of two compounds; spinosyn A and spinosyn D.
Inositol API Market Size & Trends and Manufacturers in China PharmaSources.com
July 28, 2021
This chemical is carbocyclic sugar. It is found in abundant quantities in the mammalian brain and other tissues.
Cefdinir API Market Size & Trends PharmaSources
July 13, 2021
Cefdinir is a 3rd generation cephalosporin (antibiotic). It is used to treat gram-negative and gram-positive infections of the sinus, throat, lungs, skin, and ear.
Formulation development of New chemical Entities (NCE’s) to commercialization Deepak Hegde
June 16, 2021
The process of taking a new drug from concept to clinic and eventually to commercialization involves several steps which traditionally occur in series.
Continuous Manufacturing Part 2: Industrial Adoption of Continuous Pharmaceutical Manufacturing Deepak Hegde
May 10, 2021
This article, which is Part 2 of the series on continuous manufacturing focuses on the uptake of continuous manufacturing by the pharmaceutical industry for both API and drug products, scaleup to pilot scale and successes in commercialization.
Sevoflurane Introduction, Uses, and Top Sevoflurane API Manufacturers in China PharmaSources.com
May 08, 2021
Side Effects，Manufacturing Process，Sevoflurane Forms and Specifications，ect., of Sevoflurane

Previous page 1 2 3 4 5 6 7 8 9 10 ... 21 22 Next page